FDA Inspection 1147081 — Kadesh International
The FDA completed an inspection of Kadesh International on July 15, 2021 in Garden Grove, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Unapproved and Misbranded Drugs
- Location
- Garden Grove, CA (United States)